AKT1, SRC, and VEGFA were found to have the binding energy of < −5 kcal/mol with all key targets of diabetic retinopathy (Table 4), suggesting the good binding energy towards the key targets of diabetic retinopathy. This evidence concerns the gene VEGFA and diabetic retinopathy.